C12Y 206/01007
Kynurenine--oxoglutarate transaminase
Official title: Kynurenine--oxoglutarate transaminase (2.6.1.7)
C12Y206/01007 (Kynurenine--oxoglutarate transaminase) appears on 1 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 6
- Assignees
- 12
- Inventors
- 19
- Latest grant
- 27 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof26 Feb 2026US 2026/0053924 A1
- Production of fatty alcohols in peroxisome of yarrowia lipolytica12 Feb 2026US 2026/0043055 A1University of Delaware
- Kynurenine aminotransferase and products thereof for the treatment of arthritic diseases4 Dec 2025US 2025/0367269 A1Assistance Publique-Hopitaux de Paris
- Kynurenine aminotransferase and products thereof for the treatment of inflammatory bowel diseases12 Dec 2024US 2024/0408183 A1Assistance Publique-Hopitaux de Paris
- Pharmaceutical compositions for the treatment of cancer22 Jul 2021US 2021/0220310 A1Seleq Oy
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.